The effect of surgically induced ischaemia on gene expression in a colorectal cancer xenograft model

British Journal of Cancer

Volumn 94, Issue 1, 2006, Pages 121-127

  Atkin, G ^a,d   Daley, F M ^a   Bourne, S ^a   Glynne Jones, R ^a   Northover, J ^b   Wilson, G D ^c  

^a MOUNT VERNON HOSPITAL   (United Kingdom)

^b ST MARK S HOSPITAL   (United Kingdom)

^c WAYNE STATE UNIVERSITY   (United States)

^d NONE   (United Kingdom)

Author keywords

Gene expression; Hypoxia; Thymidylate synthase

Indexed keywords

BIOLOGICAL MARKER; CARBONATE DEHYDRATASE IX; CYCLIN A; DIHYDROPYRIMIDINE DEHYDROGENASE; MESSENGER RNA; THYMIDYLATE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL OCCLUSION; CANCER MODEL; CANCER SURGERY; COLORECTAL CANCER; COLORECTAL SURGERY; CONTROLLED STUDY; CORRELATION ANALYSIS; EXPERIMENTAL MODEL; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HYPOXIA; IMMUNOHISTOCHEMISTRY; ISCHEMIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE FIXATION; TUMOR XENOGRAFT;

ANIMALS; CELL HYPOXIA; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; ISCHEMIA; MICE; MICE, SCID; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; THYMIDYLATE SYNTHASE; TRANSPLANTATION, HETEROLOGOUS; TUMOR MARKERS, BIOLOGICAL;

EID: 30644471480     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6602905     Document Type: Article

References (44)

1. Adlard JW, Richman SD, Seymour MT, Quirke P (2002) Prediction of the response of colorectal cancer to systemic therapy. Lancet Oncol 3(2): 75-82
2. Almeida A, Paul Thiery J, Magdelenat H, Radvanyi F (2004) Gene expression analysis by real-time reverse transcription polymerase chain reaction: influence of tissue handling. Anal Biochem 328(2): 101-108
3. Aschele C, Lonardi S, Monfardini S (2002) Thymidylate synthase expression as a predictor of clinical response to fluoropyrimidine-based chemotherapy in advanced colorectal cancer. Cancer Treat Rev 28(1): 27-47
4. Barber P, Vojnovic B, Atkin G, Daley F, Everett S, Wilson G, Gilbey J (2003) Applications of cost-effective spectral imaging microscopy in cancer research. J Phys D: Appl Phys 36: 1729-1738
5. 2 in muscle cells in culture. Am J Physiol 262(3 Part 1): C682-C690
6. Beck A, Etienne MC, Cheradame S, Fischel JL, Formento P, Renee N, Milano G (1994) A role for dihydropyrimidine dehydrogenase and thymidylate synthase in tumour sensitivity to fluorouracil. Eur J Cancer 10(22): 1517-1522
7. Bergeron M, Yu AY, Solway KE, Semenza GL, Sharp FR (1999) Induction of hypoxia-inducible factor-1 (HIF-1) and its target genes following focal ischaemia in rat brain. Eur J Neurosci 11(12): 4159-4170
8. Chaplin DJ, Horsman MR (1994) The influence of tumour temperature on ischemia-induced cell death: potential implications for the evaluation of vascular mediated therapies. Radiother Oncol 30(1): 59-65
9. Dachs GU, Tozer GM (2000) Hypoxia modulated gene expression: angiogenesis, metastasis and therapeutic exploitation. Eur J Cancer 36(13 Spec no): 1649-1660
10. Denekamp J, Hill SA, Hobson B (1983) Vascular occlusion and tumour cell death. Eur J Cancer Clin Oncol 19(2): 271-275
11. Derenzini M, Montanaro L, Trere D, Chilla A, Tazzari PL, Dall'Olio F, Ofner D (2002) Thymidylate synthase protein expression and activity are related to the cell proliferation rate in human cancer cell lines. Mol Pathol 55(5): 310-314
12. Edler D, Hallstrom M, Johnston PG, Magnusson I, Ragnhammar P, Blomgren H (2000) Thymidylate synthase expression: an independent prognostic factor for local recurrence, distant metastasis, disease-free and overall survival in rectal cancer. Clin Cancer Res 6(4): 1378-1384
13. Edler D, Hallstrom M, Ragnhammar P, Blomgren H (2002) Thymidylate synthase expression in rectal cancer and proliferation, assessed by cyclin A and Ki-67 expression. Anticancer Res 22(5): 3113-3116
14. Ehrnrooth E, Von Der Maase H, Sorensen BS, Hjelm Poulsen J (1999) The ability of hypoxia to modify the gene expression of thymidylate synthase in tumour cells in vivo. Int J Radiat Biol 75(7): 885-891
15. Eickelberg O, Seebach F, Riordan M, Thulin G, Mann A, Reidy KH, Van Why SK, Kashgarian M, Siegel N (2002) Functional activation of heat shock factor and hypoxia-inducible factor in the kidney. J Am Soc Nephrol 13(8): 2094-2101
16. Giaccia A, Siim BG, Johnson RS (2003) HIF-1 as a target for drug development. Nat Rev Drug Discov 2(10): 803-811
17. Gillies RJ, Raghunand N, Karczmar GS, Bhujwalla ZM (2002) MRI of the tumor microenvironment. J Magn Reson Imaging 16(4): 430-450
18. Gunaratnam L, Morley M, Franovic A, De Paulsen N, Mekhail K, Parolin DA, Nakamura E, Lorimer IA, Lee S (2003) Hypoxia inducible factor activates the transforming growth factor-alpha/epidermal growth factor receptor growth stimulatory pathway in VHL(-/-) renal cell carcinoma cells. J Biol Chem 278(45): 44966-44974
19. Helfman T, Falanga V (1993) Gene expression in low oxygen tension. Am J Med Sci 306(1): 37-41
20. Huang J, Qi R, Quackenbush J, Dauway E, Lazaridis E, Yeatman T (2001) Effects of ischemia on gene expression. J Surg Res 99(2): 222-227
21. Hui EP, Chan AT, Pezzella F, Turley H, To KF, Poon TC, Zee B, Mo F, Teo PM, Huang DP, Gatter KC, Johnson PJ, Harris AL (2002) Coexpression of hypoxia-inducible factors 1alpha and 2alpha, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival. Clin Cancer Res 8(8): 2595-2604
22. Janssen HL, Haustermans KM, Sprong D, Blommestijn G, Hofland I, Hoebers FJ, Blijweert E, Raleigh JA, Semenza GL, Varia MA, Balm AJ, van Velthuysen ML, Delaere P, Sciot R, Begg AC (2002) HIF-1A, pimonidazole, and iododeoxyuridine to estimate hypoxia and perfusion in human head-and-neck tumors. Int J Radiat Oncol Biol Phys 54(5): 1537-1549
23. Kunz M, Ibrahim SM (2003) Molecular responses to hypoxia in tumor cells. Mol Cancer 2(1): 23
24. Kuwai T, Kitadai Y, Tanaka S, Onogawa S, Matsutani N, Kaio E, Ito M, Chayama K (2003) Expression of hypoxia-inducible factor-lalpha is associated with tumor vascularization in human colorectal carcinoma. Int J Cancer 105(2): 176-181
25. Lal A, Peters H, St Croix B, Haroon ZA, Dewhirst MW, Strausberg RL, Kaanders JH, van der Kogel AJ, Riggins GJ (2001) Transcriptional response to hypoxia in human tumors. J Natl Cancer Inst 93(17): 1337-1343
26. Lando D, Peet DJ, Whelan DA, Gorman JJ, Whitelaw ML (2002) Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch. Science 295(5556): 858-861
27. Leichman CG, Lenz HJ, Leichman L, Danenberg K, Baranda J, Groshen S, Boswell W, Metzger R, Tan M, Danenberg PV (1997) Quantitation of intratumoral thymidylate synthase expression predicts for disseminated colorectal cancer response and resistance to protracted-infusion fluorouracil and weekly leucovorin. J Clin Oncol 15(10): 3223-3229
28. Liu J, Schmitz J, Lin X, Tai N, Yan W, Farrell M (2002) Thymidylate synthase as a translational regulator of cellular gene expression. Biochim Biophys Acta 1587: 174-182
29. Loncaster JA, Harris AL, Davidson SE, Logue JP, Hunter RD, Wycoff CC, Pastorek J, Ratcliffe PJ, Stratford IJ, West CM (2001) Carbonic anhydrase (CA IX) expression, a potential new intrinsic marker of hypoxia: correlations with tumor oxygen measurements and prognosis in locally advanced carcinoma of the cervix. Cancer Res 61(17): 6394-6399
30. Mattern J, Kallinowski F, Herfarth C, Volm M (1996) Association of resistance-related protein expression with poor vascularization and low levels of oxygen in human rectal cancer. Int J Cancer 67(1): 20-23
31. Miyatake Y, Ikeda H, Michimata R, Koizumi S, Ishizu A, Nishimura N, Yoshiki T (2004) Differential modulation of gene expression among rat tissues with warm ischemia. Exp Mol Pathol 77(3): 222-230
32. Nishi H, Nishi KH, Johnson AC (2002) Early growth response-1 gene mediates up-regulation of epidermal growth factor receptor expression during hypoxia. Cancer Res 62(3): 827-834
33. Okonkwo A, Musunuri S, Talamonti M, Benson III A, Small Jr W, Stryker SJ, Rao MS (2001) Molecular markers and prediction of response to chemoradiation in rectal cancer. Oncol Rep 8(3): 497-500
34. Parkins CS, Hill SA, Stratford MR, Dennis MF, Chaplin DJ (1997) Metabolic and clonogenic consequences of ischaemia reperfusion insult in solid tumours. Exp Physiol 82(2): 361-368
35. Paulding WR, Czyzyk-Krzeska MF (2000) Hypoxia-induced regulation of mRNA stability. Adv Exp Med Biol 475: 111-121
36. Powell JD, Elshtein R, Forest DJ, Palladino MA (2002) Stimulation of hypoxia-inducible factor-1 alpha (HIF-1alpha) protein in the adult rat testis following ischemic injury occurs without an increase in HIF-1alpha messenger RNA expression. Biol Reprod 67(3): 995-1002
37. Sadahiro S, Suzuki T, Ishikawa K, Nakamura T, Kamijo A, Saguchi T, Yasuda S, Tajima T, Makuuchi H, Murayama C (2003) The stability of dihydropyrimidine dehydrogenase activity in colorectal cancer tissue after resection. Oncol Rep 10(4): 867-869
38. Takenoue T, Nagawa H, Matsuda K, Fujii S, Nita ME, Hatano K, Kitayama J, Tsuruo T, Muto T (2000) Relation between thymidylate synthase expression and survival in colon carcinoma, and determination of appropriate application of 5-fluorouracil by immunohistochemical method. Ann Surg Oncol 7(3): 193-198
39. Van der Wilt CL, Peters GJ (1994) New targets for pyrimidine antimetabolites in the treatment of solid tumours. 1: Thymidylate synthase. Pharm World Sci 16(2): 84-103
40. Wahl MI, Carpenter G (1987) Role of growth factors and their receptors in the control of normal cell proliferation and cancer. Clin Physiol Biochem 5(3-4): 130-139
41. Werner M, Chott A, Fabiano A, Battifora H (2000) Effect of formalin tissue fixation and processing on immunohistochemistry. Am J Surg Pathol 24(7): 1016-1019
42. Wiesener MS, Turley H, Allen WE, Willam C, Eckardt KU, Talks KL, Wood SM, Gatter KC, Harris AL, Pugh CW, Ratcliffe PJ, Maxwell PH (1998) Induction of endothelial PAS domain protein-1 by hypoxia: characterization and comparison with hypoxia-inducible factor-1alpha. Blood 92(7): 2260-2268
43. Wykoff CC, Beasley NJ, Watson PH, Turner KJ, Pastorek J, Sibtain A, Wilson GD, Turley H, Talks KL, Maxwell PH, Pugh CW, Ratcliffe PJ, Harris AL (2000) Hypoxia-inducible expression of tumor-associated carbonic anhydrases. Cancer Res 60(24): 7075-7083
44. Zhong H, De Marzo AM, Laughner E, Lim M, Hilton DA, Zagzag D, Buechler P, Isaacs WB, Semenza GL, Simons JW (1999) Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res 59(22): 5830-5835